ALPHACENTRIC ADVISORS LLC Relmada Therapeutics, Inc. Transaction History

ALPHACENTRIC ADVISORS LLC portfolio value:

$204,000
portfolio value

Relmada Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 5.5K shares 204K $37.02 5.5K